9 results
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
of the prescription drug supply chain and prescription drug pricing. Proposals include a significant overhaul of the Medicare Part D benefit design efforts to cap … and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship … .
In addition, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices
S-1/A
COYA
Coya Therapeutics Inc
5 Dec 22
IPO registration (amended)
8:16am
and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing … been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have
S-1
dn3sf3
18 Nov 22
IPO registration
5:06pm
DRS/A
ghgtzi
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
i7s5g
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
pkjk2r
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next